Thiazolidinedione
Abbreviation: TZDs
An oral anti-diabetic medication for Type 2 diabetes. Increases insulin sensitivity in muscle, fat, and liver cells
Extended Release/ Sustained Release
Abbreviation: ER, XR, SR
Specialized formulation designed to release active ingredients slowly into the body over 8-24 hours, rather than all at once
Delayed Release
Abbreviation: DR
Formulated to release active ingredients at a later time
Enteric Coated
Abbreviation: EC
specialized barrier applied to medications to prevent them from dissolving in stomach acid. Typically releases in small intestine where pH is higher
Protects the stomach from irritation and protects sensitive drugs from stomach acid
Schedule II/Class II
C-II
Drugs with high potential for abuse, leading to severe psychological or physical dependence
Have strictly regulated but recognized medical uses
These prescriptions cannot be refilled. A new RX is required for each fill.
Schedule III/ Class III
C-III
Drugs with moderate-to-low potential for physical/psychological dependency
Prescription required.
May not be filled or refilled more than 6 months after the written date OR refilled more than 5 times, whichever comes first.
Schedule IV/ Class IV
C-IV
Substances with low potential for abuse and low risk of dependence.
Prescription required.
May not be filled or refilled more than 6 months after the written date OR refilled more than 5 times, whichever comes first.
Schedule V/ Class V
C-V
Drugs with lower potential for abuse, limited risk of dependence
Schedule V medications may be refilled as authorized by the prescriber
New Mexico Regulations state that the drug may not be filled or refilled more than 6 months after the written date OR refilled more than 5 times, whichever comes first
Schedule I/ Class I
C-I
Drugs with high abuse risk
No safe or accepted medical use in the United States
